Kythera Biopharmaceuticals
Pre-Approval PRO BETAInactive Company
No clinical trial activity in 3+ years. This company may have been acquired, shut down, or pivoted away from clinical development. Last trial started: 4/1/2014
Pipeline by Phase
Therapeutic Focus
Clinical Trials (18)
Safety Study of ATX-101 (Deoxycholic Acid) in Subjects With Mild or Extreme Fullness of Submental Fat
Started: 1/1/2014
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Started: 12/1/2013
Safety Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects 65 to 75 Years of Age
Started: 4/1/2014
Open-Label Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area
Started: 8/1/2011
Patient Experience Study of Deoxycholic Acid Injection
Started: 12/1/2013
Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat
Started: 12/1/2010
Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area
Started: 2/1/2012
Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area
Started: 3/1/2012
Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat
Started: 1/1/2011
Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Started: 2/1/2009
Phase 2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat
Started: 4/1/2008
Deoxycholic Acid Injection Submental Fat (SMF) Magnetic Resonance Imaging (MRI) and Subject-reported Outcome Measures Study
Started: 12/1/2009
To Evaluate the Safety, Tolerability and to Compare the Pharmacokinetic Profile of ATX-101
Started: 10/1/2011
Dose-Escalation Safety and Pharmacokinetic Study of ATX-101
Started: 1/1/2008
Evaluation of the Effect of ATX-101 on QT/QTc Intervals
Started: 10/1/2012
Open-Label Pharmacokinetic Study of Final Formulations of ATX-101
Started: 6/1/2012
Lipid and Adipokine Profiles Following Subcutaneous Injection of ATX-101 Into Abdominal Fat Tissue
Started: 12/1/2010